Aiphanol, a multi-targeting stilbenolignan, potently suppresses mouse lymphangiogenesis and lymphatic metastasis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aiphanol, a multi-targeting stilbenolignan, potently suppresses mouse lymphangiogenesis and lymphatic metastasis
Authors
Keywords
-
Journal
ACTA PHARMACOLOGICA SINICA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-07-01
DOI
10.1038/s41401-022-00940-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characterization of Triple-Negative Breast Cancer Preclinical Models Provides Functional Evidence of Metastatic Progression
- (2019) Juan J. Arroyo-Crespo et al. INTERNATIONAL JOURNAL OF CANCER
- Phomaketide A Inhibits Lymphangiogenesis in Human Lymphatic Endothelial Cells
- (2019) Huai-Ching Tai et al. Marine Drugs
- High Tiam1 expression predicts positive lymphatic metastasis and worse survival in patients with malignant solid tumors: a systematic review and meta-analysis
- (2019) Caixia Yang et al. OncoTargets and Therapy
- Tivozanib versus sorafenib in patients with advanced renal cell carcinoma (TIVO-3): a phase 3, multicentre, randomised, controlled, open-label study
- (2019) Brian I Rini et al. LANCET ONCOLOGY
- Roles of prostaglandins in tumor-associated lymphangiogenesis with special reference to breast cancer
- (2018) Peeyush K. Lala et al. CANCER AND METASTASIS REVIEWS
- The multi-receptor inhibitor axitinib reverses tumor-induced immunosuppression and potentiates treatment with immune-modulatory antibodies in preclinical murine models
- (2018) Heinz Läubli et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer
- (2018) Jin Li et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Nicotine increases colon cancer cell migration and invasion through epithelial to mesenchymal transition (EMT): COX-2 involvement
- (2018) Simona Dinicola et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Epsin deficiency promotes lymphangiogenesis through regulation of VEGFR3 degradation in diabetes
- (2018) Hao Wu et al. JOURNAL OF CLINICAL INVESTIGATION
- LNMAT1 promotes lymphatic metastasis of bladder cancer via CCL2 dependent macrophage recruitment
- (2018) Changhao Chen et al. Nature Communications
- Inhibition of COX-2 and EGFR by Melafolone Improves Anti-PD-1 Therapy through Vascular Normalization and PD-L1 Downregulation in Lung Cancer
- (2018) Honglin Tang et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Real world prospective experience of axitinib in metastatic renal cell carcinoma in a large comprehensive cancer centre
- (2017) Margarida Matias et al. EUROPEAN JOURNAL OF CANCER
- Sorafenib combined with HER-2 targeted vaccination can promote effective T cell immunity in vivo
- (2017) Melek M.E. Sunay et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma
- (2017) J. Duerinck et al. JOURNAL OF NEURO-ONCOLOGY
- COX2/mPGES1/PGE2pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells
- (2017) Victor Prima et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor lymphangiogenesis and new drug development
- (2016) Lothar C. Dieterich et al. ADVANCED DRUG DELIVERY REVIEWS
- Advances in identification and validation of protein targets of natural products without chemical modification
- (2016) J. Chang et al. NATURAL PRODUCT REPORTS
- Resveratrol Prevents Tumor Growth and Metastasis by Inhibiting Lymphangiogenesis and M2 Macrophage Activation and Differentiation in Tumor-associated Macrophages
- (2016) Yoshiyuki Kimura et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Signaling of Prostaglandin E Receptors, EP3 and EP4 Facilitates Wound Healing and Lymphangiogenesis with Enhanced Recruitment of M2 Macrophages in Mice
- (2016) Kanako Hosono et al. PLoS One
- Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
- (2015) Padmanee Sharma et al. CELL
- Myeloid Cell COX-2 deletion reduces mammary tumor growth through enhanced cytotoxic T-lymphocyte function
- (2014) Edward P. Chen et al. CARCINOGENESIS
- Cyclooxygenase-2–dependent lymphangiogenesis promotes nodal metastasis of postpartum breast cancer
- (2014) Traci R. Lyons et al. JOURNAL OF CLINICAL INVESTIGATION
- An In Vivo Antilymphatic Screen in Zebrafish Identifies Novel Inhibitors of Mammalian Lymphangiogenesis and Lymphatic-Mediated Metastasis
- (2014) J. W. Astin et al. MOLECULAR CANCER THERAPEUTICS
- The cellular thermal shift assay for evaluating drug target interactions in cells
- (2014) Rozbeh Jafari et al. Nature Protocols
- TNFR1 mediates TNF-α-induced tumour lymphangiogenesis and metastasis by modulating VEGF-C-VEGFR3 signalling
- (2014) Hong Ji et al. Nature Communications
- Lymphatic vessels: new targets for the treatment of inflammatory diseases
- (2013) Lothar C. Dieterich et al. ANGIOGENESIS
- Upregulation of Hsp90-beta and annexin A1 correlates with poor survival and lymphatic metastasis in lung cancer patients
- (2012) Rong Biaoxue et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- SAR131675, a Potent and Selective VEGFR-3-TK Inhibitor with Antilymphangiogenic, Antitumoral, and Antimetastatic Activities
- (2012) A. Alam et al. MOLECULAR CANCER THERAPEUTICS
- Anti-tumor and anti-metastatic actions of wogonin isolated from Scutellaria baicalensis roots through anti-lymphangiogenesis
- (2012) Yoshiyuki Kimura et al. PHYTOMEDICINE
- Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2
- (2011) Traci R Lyons et al. NATURE MEDICINE
- The lymphatic vasculature in disease
- (2011) Kari Alitalo NATURE MEDICINE
- Lymphangiogenesis: Molecular Mechanisms and Future Promise
- (2010) Tuomas Tammela et al. CELL
- Difluorinated-Curcumin (CDF): A Novel Curcumin Analog is a Potent Inhibitor of Colon Cancer Stem-Like Cells
- (2010) Shailender Singh Kanwar et al. PHARMACEUTICAL RESEARCH
- Suppression of Prostate Cancer Nodal and Systemic Metastasis by Blockade of the Lymphangiogenic Axis
- (2008) J. B. Burton et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now